Clearstead Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-57
| Closed | -$5.13K | – | 2319 |
|
|
2024
Q4 | $5.13K | Sell |
57
-495
| -90% | -$44.6K | ﹤0.01% | 1714 |
|
|
2024
Q3 | $54.5K | Sell |
552
-68
| -11% | -$6.72K | ﹤0.01% | 1184 |
|
|
2024
Q2 | $57.5K | Buy |
620
+95
| +18% | +$8.81K | ﹤0.01% | 1125 |
|
|
2024
Q1 | $47.2K | Buy |
525
+498
| +1,844% | +$44.8K | ﹤0.01% | 773 |
|
|
2023
Q4 | $2.41K | Sell |
27
-19
| -41% | -$1.7K | ﹤0.01% | 1257 |
|
|
2023
Q3 | $3.36K | Buy |
46
+23
| +100% | +$1.68K | ﹤0.01% | 1319 |
|
|
2023
Q2 | $1.91K | Hold |
23
| – | – | ﹤0.01% | 1160 |
|
|
2023
Q1 | $1.75K | Buy |
23
+13
| +130% | +$991 | ﹤0.01% | 1157 |
|
|
2022
Q4 | $830 | Sell |
10
-29
| -74% | -$2.41K | ﹤0.01% | 1186 |
|
|
2022
Q3 | $3K | Hold |
39
| – | – | ﹤0.01% | 1054 |
|
|
2022
Q2 | $3K | Sell |
39
-385
| -91% | -$29.6K | ﹤0.01% | 1077 |
|
|
2022
Q1 | $38K | Sell |
424
-208
| -33% | -$18.6K | ﹤0.01% | 733 |
|
|
2021
Q4 | $71K | Buy |
632
+134
| +27% | +$15.1K | ﹤0.01% | 597 |
|
|
2021
Q3 | $63K | Buy |
498
+340
| +215% | +$43K | ﹤0.01% | 574 |
|
|
2021
Q2 | $21K | Hold |
158
| – | – | ﹤0.01% | 702 |
|
|
2021
Q1 | $21K | Sell |
158
-142
| -47% | -$18.9K | ﹤0.01% | 673 |
|
|
2020
Q4 | $42K | Hold |
300
| – | – | ﹤0.01% | 535 |
|
|
2020
Q3 | $33K | Buy |
+300
| New | +$33K | ﹤0.01% | 524 |
|